Valneva SE (INRLF)
2.58
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Valneva EPS Diluted (Quarterly) : -0.218 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | -0.5577 |
| Cellectis SA | -0.1774 |
| Transgene SA | -- |
| Innate Pharma SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.52M |
| Revenue (Quarterly) | 36.16M |
| Total Expenses (Quarterly) | 73.68M |
| Enterprise Value | 609.39M |
| Gross Profit Margin (Quarterly) | 15.29% |
| Profit Margin (Quarterly) | -103.8% |
| Earnings Yield | -36.29% |
| Normalized Earnings Yield | -36.30 |